A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
Clinical trial NCT07401381 · RECRUITING
Trial details
- NCT number
- NCT07401381
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-08
- Primary completion
- 2028-05-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.